This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
As of June 21, 2010, gemtuzumab ozogamicin is no longer available to new patients, due to concerns about whether the drug is safe and effective. Patients who are already being treated with this drug may continue their treatment, depending on their doctor's advice. To learn more, see Gemtuzumab Ozogamicin Voluntarily Withdrawn from U.S. Markets.
Gemtuzumab Ozogamicin was originally approved to treat:
- Acute myeloid leukemia that had relapsed. It was used in patients 60 years or older who were not able to receive other chemotherapy.
Gemtuzumab ozogamicin continues to be studied in the treatment of leukemia and other conditions.
More About Gemtuzumab Ozogamicin
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Gemtuzumab Ozogamicin - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Targeted Cancer Therapies - Information about the use of this drug to treat cancer.
Clinical Trials Accepting Patients
Find Clinical Trials for Gemtuzumab Ozogamicin - Check for trials from NCI's list of cancer clinical trials now accepting patients.